Vectura is a specialist inhalation CDMO that provides innovative inhaled drug development solutions to help customers bring their medicines to patients. During the course of 2020, the Procurement Team excelled in managing critical aspects of the commercial products and CDMO supply chains through the pandemic lockdowns. Materials were kept flowing to support all demand during the course of the year. This was a fantastic achievement that supported financial performance being ahead of expectations (+6.9%) and development services revenues increased by 4.4%. The Procurement team led several critical negotiations for the business that contributed significantly to the overall company EBITDA (+41.7%).